Flow cytometric evaluation of CD38 expression levels in the newly ...
We report the flow cytometric evaluation of CD38 expression in T-ALL blasts at diagnosis and the effect of cytotoxic chemotherapy on its expression in measurable residual disease (MRD), …
Flow cytometric evaluation of CD38 expression assists in …
Apr 20, 2009 · CD38 expression in follicular lymphoma and follicular hyperplasia analyzed by flow cytometry. The median fluorescent intensity of CD38 is significantly decreased in follicular …
Bright CD38 Expression by Flow Cytometric Analysis Is a
Results: Bright CD38 expression (CD38 bright) analyzed either qualitatively or semi-quantitatively was more common in DH/THL (56%) than in MYC neg DLBCL (17%) but less common …
Immunophenotype of Normal and Myelomatous Plasma-Cell …
Plasma cells (PCs) are essentially characterized by the co-expression of CD138 and CD38, which allows their identification in flow cytometry in bone marrow (BM), peripheral blood, or cell …
CD38 expression as an important prognostic factor in B-cell …
Jul 1, 2001 · Multivariate analyses showed that CD38 expression is an important prognostic factor associated with high incidence of lymph node involvement (P = .004), lower hemoglobin level …
CD38 expression is an important prognostic marker in diffuse …
CD38 expression in DLBCL cells might be useful for predicting outcomes and designing risk-adapted therapies for patients with de-novo DLBCL. Keywords: CD38; diffuse large B-cell …
Clinical Flow-Cytometric Testing in Chronic Lymphocytic Leukemia
Flow cytometry also provides important prognostic information and accurate assessment of response to therapy. Here we describe optimal specimen collection, red cell lysis, appropriate …
Multidimensional profiling of human T cells reveals high CD38 ...
Sep 24, 2024 · Spectral cytometry profiling revealed two axes of aging common to naive CD8 + and CD4 + T cells: (1) a decrease in CD38 ++ cells (RTEs) and (2) an increase in CXCR3 hi …
CD24+/CD38- as new prognostic marker for non-small cell lung …
Oct 5, 2013 · We demonstrate for the first time that the majority of NSCLC cells do not express levels of CD38 that would qualify it as a new biomarker for the disease. In contrast, we found …
Flow cytometric analysis of CD34+CD38− cells; cell frequency and ...
Nov 6, 2023 · The CD34 + CD38 − fraction should be carefully evaluated considering the nature of normal hematopoietic precursor cells, their cell frequency and immunophenotype, including …